Middleton & CO Inc Amgen Inc Transaction History

Middleton & CO Inc

$858 Million
Q2 2024

A detailed history of Middleton & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Middleton & CO Inc holds 1,276 shares of AMGN stock, worth $424,206. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,276

Previous 1,401 8.92%

Holding current value

$424,206

Previous $398,000 -0.0%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $32,843 - $39,913	-125 Reduced 8.92%	1,276 $398,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $6,392 - $7,211	-25 Reduced 1.75%	1,401 $403,000
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $37,170 - $46,148	-170 Reduced 10.65%	1,426 $383,000
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $85,708 - $101,348	-400 Reduced 20.04%	1,596 $354,000
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $81,305 - $103,308	355 Added 21.63%	1,996 $524,000
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $56,115 - $63,287	-250 Reduced 13.22%	1,641 $370,000
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $25,839 - $28,754	-112 Reduced 5.59%	1,891 $460,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $33,109 - $36,628	151 Added 8.15%	2,003 $484,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $29,832 - $34,140	150 Added 8.81%	1,852 $417,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $31,840 - $37,305	-150 Reduced 8.1%	1,702 $362,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $54,891 - $60,897	235 Added 14.53%	1,852 $451,000
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $3,328 - $3,879	-15 Reduced 0.92%	1,617 $387,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $34,728 - $38,620	-148 Reduced 8.31%	1,632 $415,000
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $143,412 - $175,986	725 Added 68.72%	1,780 $420,000
Q3 2019 Oct 21, 2019	BUY	$174.11 - $208.62 $183,686 - $220,094	1,055 New	1,055 $204,000
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $175,868 - $206,157	-1,055 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $70,824 - $82,675	-397 Reduced 27.34%	1,055 $205,000
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $76,050 - $85,421	-458 Reduced 23.98%	1,452 $268,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $22,025 - $25,740	130 Added 7.3%	1,910 $326,000
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $297,776 - $339,980	1,780	1,780 $332,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.

Account